Orthopedics Articles

Orthopedics

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fournier MR et al. – The authors will conclude by summarizing the current state of evidence on the relationship between gastric acid inhibition and the risk of fracture, and suggest management strategies for patients who require the long–term use of gastric acid inhibiting medications who also may be at risk for metabolic bone disease and fracture.

Related Articles

Osteologix to Continue Development of Osteoporosis Drug
Internet Source, 10/21/09    Relevance Score: 93%

Lifestyle increases osteoporosis risk: docs
Internet Source, 10/21/09    Relevance Score: 90%

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09    Relevance Score: 89%

A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts
Bone, 10/27/09    Relevance Score: 89%

Evaluation of Compliance with Osteoporosis Treatment Guidelines After Initiation of a Pharmacist-Run Osteoporosis Service at a Family Medicine Clinic
Annals of Pharmacotherapy, 10/15/09    Relevance Score: 89%

Today in Bone Metabolism...keeping you current

Pattern of Bone Mineral Density in Sickle Cell Disease Patients with the High-Hb F Phenotype
Acta Haematologica, 12/04/09

Monitoring osteoporosis treatment
Best Practice & Research: Clinical Rheumatology, 12/04/09

Three-dimensional osseous micro-architecture of the distal humerus: Implications for internal fixation of osteoporotic fracture
Journal of Shoulder and Elbow Surgery, 12/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address